Online citations, reference lists, and bibliographies.

Peritoneal Carcinomatosis: Natural History And Rational Therapeutic Interventions Using Intraperitoneal Chemotherapy.

P. Sugarbaker
Published 1995 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The rationale and the treatment strategies for peritoneal carcinomatosis have gained prominence over the last decade. Their definite contribution to the management of gastrointestinal cancer has been established. The significant contributions are summarized in Table 7.



This paper is referenced by
10.1245/s10434-011-1820-2
HIPEC for Peritoneal Carcinomatosis: Does an Associated Urologic Procedure Increase Morbidity?
C. Honoré (2011)
Systemic Treatment for Advanced Colorectal cancer : Bridging the gap between clinical studies and daily practice
L. Razenberg (2017)
10.4103/1011-4564.192838
Treatment of Krukenberg tumor with hyperthermic intraperitoneal chemotherapy: A report of three cases
Li-Yung Chen (2016)
10.1016/j.ejso.2019.11.515
Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases.
Judith E K R Hentzen (2019)
10.1016/J.EJSO.2019.07.008
Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM).
Andreas Larentzakis (2019)
10.1007/s00268-005-7583-9
Inhibition of Gastric Cancer Cell Adhesion in Nude Mice by Inraperitoneal Phospholipids
M. Jansen (2005)
10.1016/j.ejso.2018.07.049
Peritoneal metastases from extra-abdominal cancer - A population-based study.
M. Flanagan (2018)
10.3747/co.23.2831
Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.
J. Spiliotis (2016)
10.1159/000011847
Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies
P. Jacquet (1998)
10.5317/WJOG.V3.I1.14
Peritoneal carcinomatosis from advanced ovarian cancer: To treat or not to treat ethical issues suggested by a case study
Mirco Nicoti (2014)
10.1016/j.ejogrb.2014.05.018
Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients.
P. Cascales-Campos (2014)
10.1007/978-1-59259-219-7_15
Memorial Sloan-Kettering Cancer Center Experience with Intraperitoneal Chemotherapy for Gastric Cancer
E. O’Reilly (2000)
10.1016/S0039-6109(05)70211-5
Significance and management of local recurrences and limited metastatic disease in the abdomen.
T. Windham (2000)
10.1002/JSO.10000
Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis.
K. Ridwelski (2002)
10.1136/gutjnl-2011-300629
Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp−−/rag2−− mice
F. Gebauer (2012)
10.1007/s10147-018-1301-8
Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
G. Tan (2018)
10.1080/02656736.2017.1301576
Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI)
Diane Goéré (2017)
10.1186/s12957-019-1646-0
Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases
Kyoji Ito (2019)
10.1007/978-1-59259-160-2_22
Surgical Management of Peritoneal Surface Spread of Colorectal Cancer
P. Sugarbaker (2002)
10.1016/j.soc.2018.02.011
Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives.
D. Goéré (2018)
10.1007/s002800051093
Successful management of microscopic residual disease in large bowel cancer
P. Sugarbaker (1999)
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands
Erasmus Mc (2015)
10.1038/s41556-017-0027-6
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas
O. Zajac (2017)
10.3748/WJG.14.6817
Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.
T. Cioppa (2008)
10.3862/JCOLOPROCTOLOGY.71.1
Surgical Outcomes of Primary Colorectal Cancer with Peritoneal Dissemination
Koichiro Yamaoku (2018)
10.5336/MEDSCI.2011-23538
Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: Morbidity and Mortality Analysis of Our Patients
K. Karadayi (2012)
10.3748/WJG.V10.I9.1372
Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer.
M. Ye (2004)
10.1007/978-3-642-19024-7_45
Lokale Applikation von Phospholipiden reduziert Peritonealkarzinose durch Magenkarzinom im Tiermodell und Tumorzelladhäsionen an Extrazellularmatrix in vitro
K. Treutner (2003)
10.1245/s10434-020-08443-4
Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Early Results from a Prospective Cohort Study of 115 Patients
D. Steffens (2020)
Management of peritoneal surface malignancy: a review of the recent literature.
E. Halkia (2014)
Staging videolaparoscopy and peritoneal citology in the colorectal carcinomas for the preoperative section of the HIPEC treatment
R. Fisichella (2017)
10.1007/s13193-018-0782-2
Cytoreductive Surgery in Combination with HIPEC in the Treatment of Peritoneal Sarcomatosis
C. Karamveri (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar